âThe Pandemic Is Acceleratingâ WHO Says As Global Coronavirus Cases Surpass 350,000
Treasury yields plunged on Monday after the Federal  Reserve committed to asset purchasing âin the amounts needed to support  smooth market functioning and effective transmission of monetary policy  to broader financial conditions and the economy.â The 10-year Treasury  yield dropped 25 basis points to 0.692%, while the yield on the 30-year  Treasury note fell 20 basis points to 1.34% ...
Â
Daxor Corp (OTC: [DXR](  Daxor shares jumped as much as 48.7% Friday after the company announced  the first use of its BVA-100 test to guide volume treatment in a  patient infected with COVID-19. âOptimal volume management and knowledge  of capillary status is key to survivability, preventing collapse of the  circulatory system and allowing time to defeat infection,â said Michael  Feldschuh, CEO of Daxor. ...
[Read More](
[#1 Coronavirus Biotech Stock](
Biotech Boom of 2020 is underway. A simple way to help secure your Wealth. Do not miss out. Company name and Ticker Symbol included. (ad)
[Click here to download your FREE special report.](
[Free Report: The Top Artificial Stocks to Invest in Right Now](
The age of artificial intelligence (AI) is here. And it could very well transform just about everything, creating a multi-billion-dollar opportunity in the process Along the way, it could create an industry worth up to $118.6 billion by 2025. We've put together a list of the hottest AI stock to consider right now, which can be viewed in our special report. (ad)
[Report Here](
Is GOLD another good proxy for defensive positioning with precious metals?
Itâs always interesting to watch the way market sentiment and investor  attention shifts over time. Just a month ago, investors were talking  about how long the economy was going to keep growing, especially as  trade concerns receded, the Fed talked about maintaining growth, and  consumer sentiment seemed high on the bullish side.
[Read More](
Â
[He's Picked a New Takeover Every 70 Days!]( - Every deal this Wall Street legend picked was taken over just 88 days after he recommended it, on average. And they each delivered average profits of 86.6%. His latest takeover could happen even faster, after a Big Pharma giant took an 11% stake in this small biotech LAST MONTH. (ad) [Get Dylan's next takeover target right here ](
Featured Stock
[Fresh Del Monte Produce Inc. (FDP) â Buy Target â $35.50 or better](
Fresh Del Monte Produce Inc., through its subsidiaries, produces,   markets, and distributes fresh and fresh-cut fruits and vegetables in   North America, Europe, the Middle East, Africa, Asia, and   internationally. It offers fresh and value added products, such as   pineapples, melons, grapes, apples, citrus, blueberries, strawberries,   pears, tomatoes, peaches, plums, nectarines, cherries and kiwis,   avocados, fresh-cut and prepared fruits and vegetables, juices and other   beverages, prepared meals and snacks, bananas, and other fruits and   vegetables. Â
Other Top Stories
[Hill talks continue as Trump appears to waffle on shutdown](
[PG&E pleading guilty to involuntary manslaughter in wildfire](
[Fitness enthusiasts think outside the gym during coronavirus](
[Liz Weston: How to create a retirement paycheck that lasts](
Â
Sponsor
[You Could Make $300 to $1100 Per Contract With This Simple Trade](
Imagine getting really good at mastering just ONE simple trade. A trade that appears like clockwork between 9:30-10:45am on most trading days. This free step-by-step guide, by options expert, Dave Acquino, shows you how to spot and take these trades so you can walk away with daily profits!
[CLICK HERE for instant access.](
Â
Trend Following Picks
Â
[UNFI) â Buy Target â $11.50 or better](
[(ZOOM) â Buy Target â $11.00 or better](
[(MRNA) â Buy Target â Â $35.00 or better](
[(SMMT) â Buy Target â $2.75 or better](
[(VHC) â Buy Target â $6.00 or better](
[(LRN) â Buy Target â $23.50 or better](
[All Picks](
Reversal Picks
[(VGZ) Buy Target $0.56 Sell Target $0.68](
[(CANF) Buy Target $2.22 Â Sell Target $2.92](
[(INSW) Buy Target $22.87 Â Sell Target $26.13](
[(FRO) Buy Target $9.20 Â Sell Target $10.78](
[(TK) Buy Target $3.91 Sell Target $4.57](
[All Picks](
Â
Already subscribed to our premium service?
[Click here to Login](
Not a TradersPro subscriber yet?
[Learn More About TradersPro Here - Â Learn The # 1 Key To Successful Stock Investing Profits](
Â
                             Â
---------------------------------------------------------------
This email was sent to {EMAIL} by Investiv, LLC
265 N. Main | Ste. D #283 | Kaysville | UT | 84037
[Forward to a friend]( | [Unsubscribe]( or [Mange which emails you get from TradersPro](
Disclaimers
Investing is Inherently Risky
There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses.
Hypothetical Results Are Reported
Results and examples used in the Companyâs advertisements, books, videos, websites, and other mediaâincluding on the Site and the Networkâare, in some cases, based on hypothetical (simulated) trades. Plainly speaking, these trades were not actually executed. Hypothetical performance results have certain limitations. Unlike an actual performance record, hypothetical results do not represent actual trading. Also, since the trades have not been executed, the hypothetical results may have under-or-over compensation for the impact, if any, of certain market factors, such as lack of liquidity. Hypothetical trading programs generally are also subject to the fact that they are designed with the benefit of hindsight. Hypothetical results also do not account for commissions or slippage.
The Companyâs simulations assume purchase and sale prices believed to be attainable. Yet traders are going to be getting into trades at different times and using various exit approaches, which may result in different pricing and outcomes. You may or may not receive the best available price on the purchase or the sale of a position in actual trading.
Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Companyâs software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified.
Offers Disinterested Commentary and Analysis
The Company does not receive any form of payment or other compensation for publishing information, news, research, or any other material concerning specific securities on the Network that is intended to affect or influence the value of securities. The Company, and its personnel, do not engage in front-running of recommendations and do not trade against oneâs own recommendations.
The Company and its management may benefit from an increase or decrease in the share prices of the profiled companies, and/or may have other actual or potential conflicts of interest. If a particular security featured in a newsletter publication is concurrently owned by the Company in its corporate brokerage account, or in any of the individual accounts of the Companyâs principals or analysts / writers, that fact will be disclosed. The Company, its principals, analysts and writers may choose to purchase a security or derivative featured in one of its newsletter publications, but typically will wait three (3) trading days from the date of publication before initiating said purchase.
[Disclaimers, Terms & Conditions]( | [Privacy Policy](
Copyright © 2019